ANA News

2018-02-13 – Two drugs are commonly prescribed for infants with epilepsy — but one of them seems to be much more effective than the other, a new study finds. Doctors looked at 155 infants who received either levetiracetam or phenobarbital for nonsyndromic epilepsy. After six months of treatment, 40 percent of…

Read More

2018-02-09 – National Institutes of Health scientists developing a rapid, practical test for the early diagnosis of prion diseases have modified the assay to offer the possibility of improving early diagnosis of Parkinson’s disease and dementia with Lewy bodies. The group, led by NIH’s National Institute of…

Read More

2018-02-08 – Research into curious bright spots in the eyes on stroke patients’ brain images could one day alter the way these individuals are assessed and treated. A team of scientists lead by ANA member Richard Leigh, MD at the National Institutes of Health found that a chemical routinely given to stroke…

Read More

2018-02-07 – The supplement nicotinamide riboside (NR) – a form of vitamin B3 – prevented neurological damage and improved cognitive and physical function in a new mouse model of Alzheimer’s disease. The results of the study, conducted by researchers at the National Institute on Aging (NIA) part of the National…

Read More

2018-01-31 – In her lab at Brigham and Women’s Hospital in Boston, Choi-Fong Cho is growing tiny, balled-up versions of the blood-brain barrier, one of neuroscience’s most notorious opponents. Learn more about Dr. Cho's research: This scientist is creating tiny versions of one of neuroscience’s most notorious…

Read More

2018-01-30 – The National Institutes of Health is teaming with government, biopharmaceutical, life science and non-profit organizations to overcome obstacles and increase success for advancing promising treatments for Parkinson’s disease (PD). Part of the NIH Accelerating Medicines Partnership (AMP), AMP PD…

Read More

2018-01-29 – The apolipoprotein E e4 allele is well known for its association with amyloid deposition in Alzheimer’s disease, but now it also appears to help drive the other key pathological process in the disease: deposition of hyperphosphorylated tau protein. This PET neuroimaging study was authored by senior…

Read More

2018-01-25 – Advances in brain imaging can identify a greater number of stroke patients who can receive therapy later than previously believed, according to a new study. The results of the Endovascular Therapy Following Imaging Evaluation for the Ischemic Stroke (DEFUSE 3) trial, presented at the International…

Read More

2018-01-22 – New research from ANA member Costantino Iadecola, M.D., director and chair of the Feil Family Brain and Mind Research Institute at Weill Cornell Medical School, links changes in the gut caused by a high-salt diet to impaired blood flow in the brain. This reduced blood flow can eventually lead to…

Read More

2018-01-19 – ANA member and winner of the ANA Distinguished Neurology Teacher Award Nina Schor, M.D., Ph.D., was named Deputy Director of the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health.  “Dr. Schor’s experience running a large university department…

Read More